COGNITION THERAPEUTICS, INC.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About CGTX
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of small molecule therapeutics targeting age-related degenerative disorders of the central nervous system and retina. The Company is investigating its lead candidate, zervimesine (CT1812), in clinical programs in dementia with Lewy bodies (DLB) and Alzheimer’s disease. Its CT1812 and pipeline of sigma-2 modulators can regulate pathways that are impaired in these diseases for the treatment of degenerative diseases. Its lead product candidate, CT1812, is an orally delivered, small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins. Its pipeline candidates were discovered using proprietary biology and chemistry platforms designed to identify novel drug targets and disease-modifying therapies that address dysregulated pathways. It is developing other product candidates in the area of synucleinopathies.
Find out what a historical investment in COGNITION THERAPEUTICS, INC. would be worth today using our CGTX stock calculator.
$35.21M
-
0.00%
18.68M
$0.67
$0.59
$0.63
$2.54
$0.22
Ready to start your investing journey with Stake?
Open an accountCGTX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CGTX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CGTX
on Stake
Buy CGTX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of CGTX from only US$10 with fractional shares
